SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-000224
Filing Date
2024-01-02
Accepted
2024-01-02 07:46:36
Documents
15
Period of Report
2024-01-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d602001d8k.htm   iXBRL 8-K 27630
2 EX-99.1 d602001dex991.htm EX-99.1 10139
7 GRAPHIC g602001g1230003236023.jpg GRAPHIC 6119
  Complete submission text file 0001193125-24-000224.txt   214567

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA xoma-20240102.xsd EX-101.SCH 3867
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xoma-20240102_def.xml EX-101.DEF 14108
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE xoma-20240102_lab.xml EX-101.LAB 23492
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xoma-20240102_pre.xml EX-101.PRE 15141
9 EXTRACTED XBRL INSTANCE DOCUMENT d602001d8k_htm.xml XML 6649
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 24500246
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)